CLCN6

Chr 1

Cl-/H+ antiporter 6

Also known as: CLC-6, CONRIBA

This gene encodes a member of the voltage-dependent chloride channel protein family. Members of this family can function as either chloride channels or antiporters. This protein is primarily localized to late endosomes and functions as a chloride/proton antiporter. Alternate splicing results in both coding and non-coding variants. Additional alternately spliced variants have been described but their full-length structure is unknown. [provided by RefSeq, Mar 2012]

ResearchGenerating clinical summary…
MultiplemechanismLOEUF 0.61
Clinical SummaryCLCN6
🧬
Gene-Disease Validity (ClinGen)
neurodegeneration, childhood-onset, with hypotonia, respiratory insufficiency, and brain imaging abnormalities · ADModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
2 unique Pathogenic / Likely Pathogenic· 549 VUS of 1058 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.61LOEUF
pLI 0.000
Z-score 3.78
OE 0.42 (0.300.61)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.59Z-score
OE missense 0.81 (0.750.87)
439 obs / 543.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.42 (0.300.61)
00.351.4
Missense OE?0.81 (0.750.87)
00.61.4
Synonymous OE?1.08
01.21.6
LoF obs/exp: 21 / 49.7Missense obs/exp: 439 / 543.5Syn Z: -0.89
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongCLCN6-related developmental disorderOTHERAD

This gene — mechanism propensity

DN
0.76top 25%
GOF
0.75top 25%
LOF
0.2385th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). The Badonyi & Marsh model scores dominant-negative highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports gain-of-function. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFA Recurrent Gain-of-Function Mutation in CLCN6, Encoding the ClC-6 Cl -/H +-Exchanger, Causes Early-Onset Neurodegeneration1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 33217309

ClinVar Variant Classifications

1058 submitted variants in ClinVar

Classification Summary

Pathogenic2
VUS549
Likely Benign433
Benign39
Conflicting4
2
Pathogenic
549
VUS
433
Likely Benign
39
Benign
4
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
2
0
0
2
Likely Pathogenic
0
0
0
0
0
VUS
33
473
32
11
549
Likely Benign
0
8
211
214
433
Benign
0
1
23
15
39
Conflicting
4
Total334842662401,027

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

40 pathogenic / likely-pathogenic (of 58) ClinVar copy-number / structural variants overlap CLCN6 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CLCN6 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →